Combat Effectiveness Boosted Fivefold! New "Smart" Immune Cells Precisely Target and Eliminate Cancer Cells
Release time:
2025-04-18
Imagine if immune cells in the human body could transform into "smart missiles," relentlessly tracking and destroying cancer cells without harming healthy tissue—this would revolutionize cancer treatment. A groundbreaking announcement from the USC Viterbi School of Engineering reveals the arrival of "EchoBack CAR T cells", a new breed of "thinking" immune warriors propelling targeted cancer therapy into a 2.0 era!
From "Blitzkrieg" to "Prolonged Warfare": Immune Cells Upgrade Combat Tactics
While traditional CAR T-cell therapies have shown success against blood cancers, their activity often fades within 24 hours. In contrast, USC’s EchoBack cells are "endurance champions": a single ultrasound activation keeps them battle-ready for five days, continuously releasing anti-cancer munitions.
"With first-generation cells, patients might need daily hospital visits. But the new cells could reduce treatment frequency to biweekly sessions, or even less," explains Longwei Liu, Assistant Professor at USC Viterbi.
In prostate cancer and glioblastoma mouse models, two rounds of ultrasound stimulation boosted tumor clearance efficiency by 300% compared to conventional therapies. Remarkably, as cancer cells counterattack, these "smart hunters" grow fiercer, producing more lethal molecules.
Precision Navigation + Self-Destruct Protocol: Dual Safeguards for Safety
The breakthrough lies in an "ultrasound switch" design:
Targeted Activation: A 10-minute, non-invasive ultrasound pulse pinpoints tumor regions, acting like GPS for CAR T cells.
Intelligent Recognition: Activated cells deploy "molecular probes" to track cancer cells like heat-seeking missiles.
Safe Self-Destruction: Anti-cancer receptors degrade automatically post-mission, preventing collateral damage.
"This is a true breakthrough," adds Yingxiao Wang, Chair of USC’s Alfred E. Mann Department of Biomedical Engineering. "It paves the way for ultrasound-controlled CAR T therapies to become clinically viable."
From Lab to Clinic: A New Era in Cancer Treatment
The technology has shown promise across multiple solid tumor models. The team is advancing clinical trials and aims to adapt this modular platform for other cancers, such as breast cancer and retinoblastoma.
Published in Cell, this study not only redefines CAR T therapy but also expands the boundaries of precision medicine. If successfully translated, this "perpetual-motion-like" smart immunotherapy could slash treatment frequency and side effects, offering hope for advanced solid tumor patients. As the researchers declare: "This isn’t just an upgrade—it’s a complete paradigm shift in cancer treatment."
Latest developments
In January 2025, members of the Yinfeng cryomedicine team actively participated in the "Sino-French Aerial Emergency Medical Rescue Training" and obtained certification. This signifies a further enhancement of the team's professional capabilities in the field of international emergency medical rescue.
Brands are an important symbol of high-quality development. Under the drive of strategies such as Brand Strong Province and Good Products Shandong, Shandong brands have risen to prominence. Particularly in recent years, Shandong brands have focused on new quality productivity, using "new" to enhance quality, achieving remarkable results in high-quality development.
With infinite hope for future medical technology, I applied to become a member of the Yinfeng Life Extension Program and volunteered to contribute to cryobiology in a hundred years by becoming a cryonics volunteer. I also believe that preservation in China is safer.
As a distinguished emblem of technological innovation in Shandong, Yinfeng's Life Continuation Project will continue to build a bridge for domestic and international government research and academic exchange, continually strengthen scientific collaborations and result transformations with global research institutions, consistently contribute to the development of cryobiomedicine, and inject continuous hope into the shared ideal of extending human life.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155507
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
